✦ LIBER ✦

Combination therapy with rituximab and interferon (IFN)-α-2a is `active, safe, and well tolerated' in patients with non-Hodgkin's lymphoma

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-α-2b beneficial in patients w

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Cladribine combined with cyclophosphamid

✍ Robak, Tadeusz; Lech-Maranda, Ewa; Janus, Agnieszka; Blonski, Jerzy; Wierzbowska 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 389 KB

Final analysis of the ECOG I-COPA trial

✍ Smalley, R V; Weller, E; Hawkins, M J; Oken, M M; O’Connell, M J; Haase-Statz, S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Results of a fludarabine induction and α

✍ P. L. Zinzani; M. Bendandi; M. Magagnoli; D. Rondelli; A. de Vivo; M. Benni; E. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Efficacy, quality of life, safety, and t

✍ Kenneth D. Rothstein; Robert P. Perrillo; Joanne Imperial; Imtiaz Alam; Melissa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 366 KB

CHOP-like regimen in combination with ri

✍ Shu-qing Lü; Jian-min Yang; Xian-min Song; Li Chen; Wei-ping Zhang; Xiao-qian Xu 📂 Article 📅 2010 🏛 Springer-Verlag ⚖ 423 KB